- Transcript 'Moocci.CG.ELv1_2.S49...' >
- Region 'REG00000893' >
- Molecular Tool 'Prdm1-r.b mRNA (Ikeda 2017)' >
- Transcript 'Cisavi.CG.ENS81.R2.3...' >
- Transcript 'Cisavi.CG.ENS81.R2.3...'
Transcript Model
Transcript Id
Cisavi.CG.ENS81.R2.305036-327173.06279.t
Possible name(s)
EPHA4; EPHB1; EPHB2
Gene model
Location
R2 [305,601 / 325,619]
>Cisavi.CG.ENS81.R2.305036-327173.06279.p
TSDLNWALHPQTYGWEELSGRDVNGNTIRYHQVCNVDEEEQDNWVRSPFIDARSAQRVYM
DIEFSVMKCEECRETFALYYYQSSADIATSTFPPWRENPYTKIDTLAAGERFDSSTVGAE
GINRKTLVISPLSRRGFYVAAQDQGACMSLMSLKLYYYYCPETTHNLAYFSRTLSGGEVA
SLVAQSGKCVSNSVYSNNEVPKYRCNSYGEWRVPTGSCHCRAGYQPNEELTTCQGCSVGS
YKPENGNIQCQACPAHSLTRSVGADHCSCVDGYYRADGDSIHQACSRTPSQPKNITFTLN
KTSVSMNWMEPVITGERSDIFYSVACQECESGYKNCRSCPSTIQPSPSNLHHLTTTNAQL
NNLKPYSHYSIKVGLQYILLLMLGKPPAFQWVNISTSESGPPQIQRLRLVESGQTYFVVA
WMSTPTPTTHLLEYQVRVFQNGHKIKDINTFSTNATVSGLTKGSKYIAKVRVRNGMGYGK
FSNDLYVATSSAKEQATAGLNPAVIGGVMGVIAIVIIVIIVLYLDPLICCTLSTDLLHVG
NNFVSYLCGFIKVSLKLVKKTSEFLNKYGRTYVDYRDPHNGVKEIATELDQTKIKIECVI
GRGRWCLTVCRGKLISGKTSIPVAVKRLKEGASLIDHTNFLREACTMAQFDHPNIIQLKG
VVTKSKWAMIITEFMENGSLDKFLQGKVNELTASRLLEMLRGIASGMNYLSSIKYIHRDL
AARNILVSSDLVCKVSDFGLSRTLENDPQATYTTQGGKIALRWTAPECIRFRQFTSASDV
WSYGIVMWEVMSYGEKPYWDMSNEVVTEVLEDGYRLPAPENCPVSIHNLMLKCWSYEAKR
RPHPIEIIRTLDQFIKQPNLLLDTKSHDASAPLLNPDSPTSLNEVSTLDEWLDMVKLGKY
RRSFHTNGINDLESLVHISESELDRLGITSPAHRTRLQGGISTLRQHLGEFPN
>Cisavi.CG.ENS81.R2.305036-327173.06279.t
ACAAGTGACTTGAATTGGGCGCTCCACCCACAAACTTATGGGTGGGAAGAACTAAGCGGA
CGTGACGTCAACGGAAACACGATAAGATACCACCAAGTGTGCAATGTGGACGAAGAGGAA
CAAGATAACTGGGTTCGGTCGCCATTTATTGACGCAAGATCGGCTCAACGTGTTTACATG
GACATTGAGTTTTCCGTAATGAAATGCGAGGAATGTCGTGAAACATTCGCGCTGTATTAC
TACCAGTCGTCCGCTGACATCGCTACCAGCACTTTTCCACCGTGGAGGGAAAACCCCTAT
ACCAAGATCGACACGCTAGCTGCAGGGGAACGATTTGACTCGAGCACTGTAGGTGCTGAG
GGGATAAACAGGAAGACTTTGGTGATCAGTCCGCTATCAAGGCGAGGGTTCTACGTGGCA
GCCCAGGACCAAGGAGCATGCATGTCGTTGATGAGTCTCAAGTTGTATTATTATTACTGC
CCTGAGACCACGCACAACCTCGCTTATTTCTCGAGGACCTTATCAGGGGGTGAAGTCGCG
TCGCTCGTTGCGCAATCCGGCAAATGCGTCTCCAACTCCGTATACTCTAACAACGAAGTT
CCGAAATACCGCTGCAACAGCTACGGTGAATGGAGAGTACCGACTGGTTCGTGCCACTGT
CGAGCTGGCTACCAACCGAACGAAGAACTAACTACGTGCCAAGGTTGCAGTGTGGGGAGT
TACAAACCGGAGAATGGGAACATACAATGCCAAGCCTGCCCCGCACATAGCTTGACTAGG
AGCGTAGGGGCAGATCATTGTTCATGTGTGGATGGTTACTATCGAGCTGATGGAGACTCA
ATACACCAAGCTTGTTCTAGGACACCATCTCAGCCAAAGAATATCACCTTTACATTGAAC
AAAACTTCCGTTTCAATGAACTGGATGGAACCGGTTATAACTGGTGAAAGATCGGACATA
TTTTACAGTGTGGCATGCCAGGAATGCGAGAGTGGGTACAAGAACTGCCGATCATGTCCC
TCCACCATCCAACCCTCCCCTTCCAACCTCCACCACCTCACAACCACCAACGCCCAACTC
AATAACCTCAAACCATACTCTCATTATTCAATCAAGGTAGGTTTGCAATATATTTTATTG
TTAATGTTGGGGAAACCCCCTGCTTTTCAGTGGGTCAATATATCAACCAGCGAATCAGGT
CCACCCCAAATACAACGATTAAGGCTTGTAGAAAGTGGACAAACATATTTTGTGGTGGCC
TGGATGTCAACCCCCACGCCTACAACCCACTTGCTCGAATATCAAGTCAGAGTTTTCCAA
AACGGACACAAGATTAAAGACATAAACACATTCTCCACTAATGCTACAGTGAGTGGGTTA
ACCAAGGGAAGCAAATACATCGCGAAGGTCAGAGTGAGAAATGGAATGGGATACGGAAAA
TTCAGCAATGACCTTTACGTGGCCACTTCTTCGGCCAAAGAACAAGCGACTGCCGGTTTA
AACCCCGCAGTGATCGGGGGTGTGATGGGGGTGATCGCGATAGTTATCATCGTGATCATA
GTGTTGTACCTGGATCCACTGATTTGTTGCACGTTATCCACTGATTTGTTGCACGTTGGG
AATAATTTTGTTTCATACCTTTGTGGTTTTATAAAAGTTTCATTAAAATTGGTAAAAAAA
ACTTCAGAATTTCTAAACAAATATGGGCGCACCTACGTCGACTACCGAGACCCTCATAAT
GGGGTGAAGGAAATCGCAACCGAACTCGATCAAACTAAGATCAAGATCGAATGCGTCATT
GGGAGAGGTAGGTGGTGTTTAACAGTGTGCCGAGGAAAGTTGATATCGGGCAAGACTTCC
ATCCCGGTTGCCGTGAAACGCTTGAAGGAAGGAGCAAGTTTGATCGATCACACTAACTTC
TTGAGGGAAGCTTGCACAATGGCTCAGTTTGATCATCCTAACATCATCCAACTTAAAGGG
GTCGTCACTAAAAGTAAGTGGGCCATGATAATCACCGAGTTTATGGAGAATGGATCATTG
GACAAGTTTCTACAGGGCAAAGTGAATGAACTGACTGCCTCGAGGTTGCTTGAGATGTTA
CGAGGTATAGCGAGTGGGATGAACTATCTCTCCTCCATCAAATACATCCACAGAGATCTT
GCTGCTCGCAACATCCTCGTCAGTTCTGACCTCGTTTGCAAAGTTTCAGACTTCGGACTT
TCGAGGACCCTGGAAAATGACCCCCAAGCTACCTATACTACACAGGGCGGGAAGATTGCT
CTGCGCTGGACGGCACCCGAGTGCATACGCTTCCGACAATTCACGTCAGCGAGTGACGTA
TGGAGTTACGGCATCGTCATGTGGGAAGTGATGTCATACGGGGAGAAGCCATACTGGGAT
ATGAGCAATGAGGTGGTCACTGAGGTCTTGGAGGATGGATATCGCCTCCCAGCCCCTGAG
AACTGCCCAGTATCCATCCACAATCTGATGCTGAAGTGTTGGAGCTATGAAGCGAAGAGG
AGGCCTCATCCCATTGAGATCATCCGGACTTTGGATCAGTTCATCAAACAACCTAACCTC
CTCCTGGACACCAAGTCACATGACGCAAGCGCCCCACTACTCAACCCAGACAGCCCCACC
AGTTTAAACGAGGTGTCCACACTTGATGAATGGCTGGACATGGTGAAGCTTGGAAAATAT
CGTCGAAGTTTCCACACGAATGGAATCAACGACCTTGAAAGTCTGGTCCACATTAGTGAA
AGTGAGTTAGATCGACTTGGCATCACCTCCCCCGCCCACCGCACTCGACTTCAGGGAGGC
ATCAGCACGTTGAGGCAGCATTTGGGGGAATTCCCCAAC
Pfam |
Ephrin_rcpt_lig-bd_dom (IPR001090) - T[1-160] 8.4E-54 |
SUPERFAMILY |
Galactose-bd-like_sf (IPR008979) - T[1-158] 7.65E-52 |
ProSiteProfiles |
Ephrin_rcpt_lig-bd_dom (IPR001090) - T[1-165] 52.946 |
Gene3D |
Galactose-bd-like_sf (IPR008979) - T[1-160] 2.2E-56 |
PIRSF |
Tyr_kinase_ephrin_rcpt (IPR016257) - T[1-952] 0.0 |
SMART |
Ephrin_rcpt_lig-bd_dom (IPR001090) - T[1-160] 1.6E-61 |
SUPERFAMILY |
Growth_fac_rcpt_cys_sf (IPR009030) - T[197-288] 4.43E-6 - T[326-342] 4.43E-6 |
Pfam |
Tyr-kin_ephrin_A/B_rcpt-like (IPR011641) - T[223-265] 1.9E-8 |
SMART |
Tyr-kin_ephrin_A/B_rcpt-like (IPR011641) - T[223-267] 1.9E-7 |
ProSiteProfiles |
FN3_dom (IPR003961) - T[288-399] 10.478 - T[403-492] 13.42 |
SUPERFAMILY |
FN3_sf (IPR036116) - T[288-490] 1.73E-21 |
SMART |
FN3_dom (IPR003961) - T[289-384] 1.2 - T[401-479] 1.7E-6 |
Gene3D |
Ig-like_fold (IPR013783) - T[289-374] 2.6E-15 - T[387-500] 3.6E-13 |
CDD |
FN3_dom (IPR003961) - T[289-373] 3.5687E-5 - T[401-489] 2.22942E-9 |
Pfam |
FN3_dom (IPR003961) - T[290-373] 3.7E-8 - T[403-482] 7.3E-8 |
SUPERFAMILY |
Kinase-like_dom_sf (IPR011009) - T[592-862] 4.51E-73 |
SMART |
Tyr_kinase_cat_dom (IPR020635) - T[594-851] 8.0E-116 |
ProSiteProfiles |
Prot_kinase_dom (IPR000719) - T[594-855] 34.633 |
Pfam |
Ser-Thr/Tyr_kinase_cat_dom (IPR001245) - T[595-850] 2.0E-87 |
PRINTS |
Ser-Thr/Tyr_kinase_cat_dom (IPR001245) - T[672-685] 1.0E-30 - T[709-727] 1.0E-30 - T[759-769] 1.0E-30 - T[778-800] 1.0E-30 - T[822-844] 1.0E-30 |
ProSitePatterns |
Tyr_kinase_AS (IPR008266) - T[715-727] . |
SUPERFAMILY |
SAM/pointed_sf (IPR013761) - T[876-946] 6.09E-16 |
SMART |
SAM (IPR001660) - T[880-947] 1.6E-12 |
Pfam |
SAM (IPR001660) - T[883-945] 6.5E-12 |
ProSiteProfiles |
SAM (IPR001660) - T[883-947] 15.208 |
Protein Name | Identity | Bit Score | e-value |
---|---|---|---|
EPHA4_HUMAN | 40.867 % | 734 | 0 |
EPHB3_HUMAN | 40.493 % | 711 | 0 |
EPHB2_HUMAN | 41.122 % | 750 | 0 |